Impaired right Ventricular (RV) function may be caused by pulmonary hyperte
nsion or myocardial ischemia. It is characterized by a dilation of the RV,
which is followed by an increase of wall tension and O-2-consumption and a
decrease of RV ejection fraction (RV 'dysfunction'). If a drop of arterial
pressure occurs this my precipitate RV failure and shock (RV 'insufficiency
'). Diagnosis of RV failure and monitoring of RV function is difficult. Som
etimes, even a severe impairment of RV function goes undetected or is misin
terpreted. Patients in the operating room or on intensive care units seem t
o be especially prone to RV dysfunction and failure. Since a causative ther
apy often is not readily available, adequate symptomatic therapy is of utmo
st importance. Four basic principles have to be considered: 1) Optimizing p
reload: The failing RV requires adequate filling for preservation of stroke
volume. On the other hand, overdistension of the RV may result in RV ische
mia, thereby further deteriorating RV function Hence, volume loading is imp
ortant, but requires continuous monitoring. 2) Maintenance of aortic pressu
re: Vasopressors are indicated if there is a critical drop of coronary perf
usion pressure. Norepinephrine presently is the drug of choice for this pur
pose. 3) Reduction of RV/afterload: Whereas intravenous vasodilators are li
mited in their efficacy in dilating pulmonary vessels due to systemic side
effects, inhaled vasodilators result in selective pulmonary vasodilation an
d may improve RV function. 4) increase of RV/contractility: In RV failure a
nd shock, norepinephrine and epinephrine are the drugs of choice. Inodilato
rs are well suited for reducing pulmonary vascular resistance due to their
positive inotropic and vasodilating effects. Since systemic vasodilation ma
y occur, these drugs must only be used in hemodynamically stable patients.